GB1111957A - Improvements in or relating to anthelmintic compositions - Google Patents

Improvements in or relating to anthelmintic compositions

Info

Publication number
GB1111957A
GB1111957A GB2272466A GB2272466A GB1111957A GB 1111957 A GB1111957 A GB 1111957A GB 2272466 A GB2272466 A GB 2272466A GB 2272466 A GB2272466 A GB 2272466A GB 1111957 A GB1111957 A GB 1111957A
Authority
GB
United Kingdom
Prior art keywords
alkyl
carbon atoms
hydrogen
prepared
formula
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
GB2272466A
Inventor
Paul Norman Craig
John Russel Eugene Hoover
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Smith Kline and French Laboratories Ltd
Original Assignee
Smith Kline and French Laboratories Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Smith Kline and French Laboratories Ltd filed Critical Smith Kline and French Laboratories Ltd
Priority to GB2272466A priority Critical patent/GB1111957A/en
Publication of GB1111957A publication Critical patent/GB1111957A/en
Expired legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D235/00Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings
    • C07D235/02Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings condensed with carbocyclic rings or ring systems
    • C07D235/04Benzimidazoles; Hydrogenated benzimidazoles
    • C07D235/24Benzimidazoles; Hydrogenated benzimidazoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached in position 2
    • C07D235/30Nitrogen atoms not forming part of a nitro radical

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

2-Amidobenzimidazole compounds of the structural formula <FORM:1111957/C2/1> wherein A is methyl or phenyl; X is oxygen or sulphur; R is hydrogen, alkyl of 1 to 10 carbon atoms, hydroxyalkyl of 1 to 10 carbon atoms, or benzyl; R1 is hydrogen, alkyl of 1 to 10 carbon atoms, or acyl of 1 to 10 carbon atoms; and Y and Z are hydrogen, alkyl of 1 to 10 carbon atoms, alkoxy of 1 to 10 carbon atoms, trifluoromethyl, amino, alkylamino, dialkylamino, cyano, acylamino, halo, hydroxy, nitro, alkyl-thio, carboxy, carbalkoxy, carbamoyl, alkyl-carbamoyl, or dialkylcarbamoyl, all of the undefined alkyl groups having 1 to 4 carbon atoms, are prepared by condesing a 2-amino-benzimidazole with a compound of formula <FORM:1111957/C2/2> preferably in the presence of a base in a solvent, e.g. pyridines. Compounds of formula I in which Y or Z is amino are prepared of catalytic reduction of the corresponding nitro compound preferably using a palladium-on-carbon catalyst. Alternatively compounds of Formula I may be prepared by reacting the compound formed by reacting cyanamide with the selected carboxylic acid chloride in the presence of an acid-acceptor, e.g. pyridine or triethylamine, with an appropriately substituted o-phenylene diamine. Compounds in which X is sulphur may be prepared by reacting the corresponding compound in which X is oxygen with phosphorus pentasulphide, preferably in a solvent. The compounds of Formula I where R1 is alkyl and R is hydrogen are prepared by treating o-phenylene diamine with an alkyl isocyanate to form an alkyl o-aminophenylthiourea, which is cyclized to form a 2-alkylaminobenzimidazole, which is reacted with benzoyl or acetyl chloride to yield a 2-(N-alkylacylamino)benzimidazole. 1-Methyl-2-acetamidobenzimidazole and 2-(N,N-diacetylamino) - 1 - methylbenzimidazole are both prepared by the reaction of acetic anhydride with 1-methyl-2-aminobenzimidazole. Acid addition salts may be prepared in conventional manner.ALSO:Anthelmintic compositions comprise as active ingredient a 2-amidobenzidazole of the formula <FORM:1111957/A5-A6/1> wherein A is methyl or phenyl; X is oxygen or sulphur; R is hydrogen, alkyl or hydroxyalkyl of 1 to 10 carbon atoms or benzyl; R1 is hydrogen, alkyl or acyl of 1 to 10 carbon atoms; and Y and Z are hydrogen, alkyl or alkoxy of 1 to 10 carbon atoms, trifluoromethyl, amino, alkylamino, dialkylamino, cyano, acylamino, halo, hydroxy, nitro, alkylthio, carboxy, carbalkoxy, carbamoyl, alkylcarbamoyl or dialkylcarbamoyl, all of the undefined alkyl groups having 1 to 4 carbon atoms, or a pharmaceutically acceptable acid addition salt thereof, and a pharmaceutical carrier. The 2-amidobenzimidazole is preferably 2-benzamido-benzimidazole or 2-acetamidobenzimidazole and specified salts are the hydrochloride, hydrobromide, sulphate, phosphate, acetate or cyclohexylsulphamate. The compositions are administered orally in the form of an animal feed, drench or bolus, capsules, liquids or tablets which may be emperic coated or adapted for sustained release.
GB2272466A 1966-05-20 1966-05-20 Improvements in or relating to anthelmintic compositions Expired GB1111957A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
GB2272466A GB1111957A (en) 1966-05-20 1966-05-20 Improvements in or relating to anthelmintic compositions

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB2272466A GB1111957A (en) 1966-05-20 1966-05-20 Improvements in or relating to anthelmintic compositions

Publications (1)

Publication Number Publication Date
GB1111957A true GB1111957A (en) 1968-05-01

Family

ID=10184091

Family Applications (1)

Application Number Title Priority Date Filing Date
GB2272466A Expired GB1111957A (en) 1966-05-20 1966-05-20 Improvements in or relating to anthelmintic compositions

Country Status (1)

Country Link
GB (1) GB1111957A (en)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2052988A1 (en) * 1969-06-20 1971-04-16 Janssen Pharmaceutica Nv
FR2209558A1 (en) * 1972-12-12 1974-07-05 Lepetit Spa

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2052988A1 (en) * 1969-06-20 1971-04-16 Janssen Pharmaceutica Nv
FR2209558A1 (en) * 1972-12-12 1974-07-05 Lepetit Spa

Similar Documents

Publication Publication Date Title
KR880002840A (en) Imidazole compound, preparation method thereof, and pharmaceutical composition which consists of this
DE69021472D1 (en) Pyrazole derivatives, processes for their preparation and pharmaceutical compositions containing them.
HU208811B (en) Process for producton of biaryl-compounds and pharmaceutical compositions comprising them as medical agent
PT93066A (en) METHOD FOR THE PREPARATION OF HETEROCYCLIC DERIVATIVES CONTAINING BENGENIC NUCLEES CASTED WITH SUBSTITUTED MONOAZOTED NUCLEUS AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM
FI810250L (en) FRAMEWORK FOR THERAPEUTIC ACTIVATION THERAPEUTIC ACTIVE HETEROCYCLIC FOERING
CZ140696A3 (en) Hiv protease inhibitor precursors and pharmaceutical compositions containing thereof
GB966796A (en) Compositions containing substituted benzimidazoles
US4472398A (en) Condensed pyrimidines
US4163058A (en) Derivatives of 5,5-diphenylhydantoin exhibiting enhanced solubility and the therapeutic use thereof
HU193333B (en) Process for production of 2-amino-axazilons and medical preparatives containing thereof
GB1036280A (en) Imidazolidine derivatives and a process for the manufacture thereof
GB1111957A (en) Improvements in or relating to anthelmintic compositions
JPS617277A (en) Therapeutical compound
US3590045A (en) Certain substituted imidazo (4,5-b)pyridines
GB1212460A (en) Naphthacene derivatives
Askew et al. Nonpeptide glycoprotein IIb/IIIa inhibitors. 13. design and synthesis of an orally active pyrazolopiperazinone nonpeptide fibrinogen receptor antagonist
US3836658A (en) Tri-substituted imidazoles in the treatment of gout
US3740413A (en) 2-benzimidazolecarboxamides
ES8203875A1 (en) 1-Benzoxepin-5(2H)-one derivatives and their salts, and processes for their preparation.
FR2464259A1 (en) NOVEL 5- (2-CHLOROPHENYL) -6H-1,3,4-THIADIAZIN-2-AMINES, IN PARTICULAR USE AS ANTICONVULSIVANTS, AND PROCESS FOR THE PREPARATION THEREOF
JPS60184081A (en) 7,8-dihydroimidazo(1,5-a)pyrazine-8-ones
AU2015218949A1 (en) Compositions and methods for drug sensitization of parasites
IL41664A (en) 2,6-diamino-dihydropyridines,their production and pharmaceutical compositions containing them
US3320272A (en) Process for preparing z-alkoxycyclo- heptimidazole derivatives
GB2093450A (en) 2,1,3-benzothiadiazole derivatives